What J&J’s Spravato patent win could mean for psychedelic drugs

What J&J’s Spravato patent win could mean for psychedelic drugs is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Kelly Bilodeau · 2026-09-24

As more psychedelic drugs move toward market, developers are testing how far patent protection can extend around familiar compounds.

Source: PharmaVoice